Hilco Industrial Acquisitions, an Amsterdam-based Industrial Asset Disposition and Acquisition Company, has acquired all machinery and equipment from the Swiss-based contract manufacturing organization (CMO) Legacy Pharmaceuticals.
 
After several years of expansion, the Swiss company was forced to file for bankruptcy in December 2020. After decontamination of the facility, the Cantonal Insolvency Department Basel-Land organized a liquidation sale of all assets at the end of March 2021. It was Hilco, who put forward the best offer and removal conditions and as a result, they were awarded the acquisition of all machinery and equipment and the removal and clearance of the factory buildings.
 
Legacy Pharmaceuticals was a well-known and reputable contract manufacturer and service provider specializing in fill/finish of sterile and semi-solid drug products for the global pharmaceutical industry and used to employ more than 200 people providing one-stop-shop services from API supply, sterile drug products filling, and secondary packaging through to shipment to clients’ distribution centers worldwide.
 
Darko Pepovski, vice president of sales and marketing at Hilco in the Netherlands, says that his challenge is to bring the production capacity back to the market and vacate the 27,000 square feet of Legacy facilities within the next 6 months.
 
“To do so, we have started a worldwide marketing and sales campaign, making potential buyers in the pharmaceutical and associated industries aware of the opportunity to acquire the excellent maintained, late-model equipment needed to increase their production capacities, especially these days of high demand for injectables due to COVID,” said Pepovski. “We bring high-capacity production lines to the market, which will help to produce the increased demand for these products and fulfil the capacity needed.”
 
As part of US-based Hilco Global, Hilco Industrial Acquisitions provides industrial asset disposition and acquisition services, specializing in machinery, equipment and inventory by negotiated sales and online auctions. Hilco sells a broad range of industrial assets found in manufacturing, wholesale, and distribution companies. Hilco Industrial buys and sells assets through on-site, online, and combination webcast auction sale events as well as negotiated (private treaty) sales, and hndles the complete removal of the assets from the industrial facilities with its own project management team.
 
To learn more about the Legacy Pharmaceutical project, please visit click here.